These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35915405)

  • 21. Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study.
    Lavallée PC; Charles H; Albers GW; Caplan LR; Donnan GA; Ferro JM; Hennerici MG; Labreuche J; Molina C; Rothwell PM; Steg PG; Touboul PJ; Uchiyama S; Vicaut É; Wong LKS; Amarenco P;
    Lancet Neurol; 2023 Apr; 22(4):320-329. PubMed ID: 36931807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular Rehabilitation for transient ischaemic Attack and Mild Stroke: the CRAMS effectiveness-implementation hybrid study protocol.
    Freene N; Wallett H; Flynn A; Preston E; Cowans S; Lueck C; Niyonsenga T; Mohanty I; Davey R
    BMC Health Serv Res; 2022 Nov; 22(1):1391. PubMed ID: 36419153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of non-consensus transient ischaemic attacks with focal, negative, and non-progressive symptoms: population-based validation by investigation and prognosis.
    Tuna MA; Rothwell PM;
    Lancet; 2021 Mar; 397(10277):902-912. PubMed ID: 33676629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
    Li J; Liu J; Liu M; Zhang S; Hao Z; Zhang J; Zhang C
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009938. PubMed ID: 26346232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral antithrombotic therapy for the prevention of recurrent cerebrovascular events.
    Capodanno D; Angiolillo DJ
    Eur Heart J Cardiovasc Pharmacother; 2022 Jun; 8(4):383-391. PubMed ID: 34374741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid management in ischaemic stroke or transient ischaemic attack in China: result from China National Stroke Registry III.
    Xu YY; Chen WQ; Wang MX; Pan YS; Li ZX; Liu LP; Zhao XQ; Wang YL; Li H; Wang YJ; Meng X;
    BMJ Open; 2023 Mar; 13(3):e069465. PubMed ID: 36889830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ICARUSS, the Integrated Care for the Reduction of Secondary Stroke trial: rationale and design of a randomized controlled trial of a multimodal intervention to prevent recurrent stroke in patients with a recent cerebrovascular event, ACTRN = 12611000264987.
    Joubert J; Davis SM; Hankey GJ; Levi C; Olver J; Gonzales G; Donnan GA
    Int J Stroke; 2015 Jul; 10(5):773-7. PubMed ID: 25907853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444).
    ; Hankey GJ; Algra A; Chen C; Wong MC; Cheung R; Wong L; Divjak I; Ferro J; de Freitas G; Gommans J; Groppa S; Hill M; Spence D; Lees K; Lisheng L; Navarro J; Ranawaka U; Ricci S; Schmidt R; Slivka A; Tan K; Tsiskaridze A; Uddin W; Vanhooren G; Xavier D; Armitage J; Hobbs M; Le M; Sudlow C; Wheatley K; Yi Q; Bulder M; Eikelboom JW; Hankey GJ; Ho WK; Jamrozik K; Klijn K; Koedam E; Langton P; Nijboer E; Tuch P; Pizzi J; Tang M; Antenucci M; Chew Y; Chinnery D; Cockayne C; Loh K; McMullin L; Smith F; Schmidt R; Chen C; Wong MC; de Freitas G; Hankey GJ; Loh K; Song S
    Int J Stroke; 2007 May; 2(2):144-50. PubMed ID: 18705976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox KM; Hennerici MG; Mattle HP; Rothwell PM; de Cordoüe A; Fratacci MD;
    Lancet; 2011 Jun; 377(9782):2013-22. PubMed ID: 21616527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis.
    Lim ST; Thijs V; Murphy SJX; Fernandez-Cadenas I; Montaner J; Offiah C; Marquardt L; Kelly PJ; Bath PM; Lim SY; Ford GA; Norrving B; Cox D; Prodan CI; Barber PA; Werring DJ; Perry R; Zgaga L; Dawson J; McCabe DJH
    J Neurol; 2020 Oct; 267(10):3021-3037. PubMed ID: 32518978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome after ischaemic stroke/transient ischaemic attack.
    Hankey GJ
    Cerebrovasc Dis; 2003; 16 Suppl 1():14-9. PubMed ID: 12698014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects on survival after a 1-year multifactorial vascular risk factor intervention after stroke or TIA: secondary analysis of a randomized controlled trial, a 7-year follow-up study.
    Hagberg G; Fure B; Sandset EC; Thommessen B; Ihle-Hansen H; Øksengård AR; Nygård S; Wyller TB; Ihle-Hansen H
    Vasc Health Risk Manag; 2019; 15():11-18. PubMed ID: 30799926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-Centered Outcomes in a Randomized Trial Investigating a Multimodal Prevention Program After Transient Ischemic Attack or Minor Stroke: The INSPiRE-TMS Trial.
    Ihl T; Ahmadi M; Laumeier I; Steinicke M; Ferse C; Klyscz P; Endres M; Hastrup S; Poppert H; Palm F; Kandil FI; Weber JE; von Weitzel-Mudersbach P; Wimmer MLJ; Audebert HJ
    Stroke; 2022 Sep; 53(9):2730-2738. PubMed ID: 35703097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protocol for Past BP: a randomised controlled trial of different blood pressure targets for people with a history of stroke of transient ischaemic attack (TIA) in primary care.
    Fletcher K; Mant J; McManus R; Campbell S; Betts J; Taylor C; Virdee S; Jowett S; Martin U; Greenfield S; Ford G; Freemantle N; Hobbs FD
    BMC Cardiovasc Disord; 2010 Aug; 10():37. PubMed ID: 20696047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and prognosis in oldest old patients with ischaemic stroke or transient ischaemic attack in China.
    Wang Y; Jing J; Pan Y; Wang M; Meng X; Wang Y
    Ann Palliat Med; 2022 Jul; 11(7):2215-2224. PubMed ID: 35272470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends and predictors of myocardial infarction or vascular death after ischaemic stroke or TIA in China, 2007-2018: insights from China National Stroke Registries.
    Li L; Pan Y; Wang M; Jing J; Meng X; Jiang Y; Guo C; Jin Z; Wang Y
    Stroke Vasc Neurol; 2021 Jun; 6(2):214-221. PubMed ID: 33127855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structured follow-up pathway to support people after transient ischaemic attack and minor stroke (SUPPORT TIA): protocol for a feasibility study and process evaluation.
    Turner GM; Jones R; Collis P; Patel S; Jowett S; Tearne S; Foy R; Atkins L; Mant J; Calvert M
    BMJ Open; 2022 Jun; 12(6):e060280. PubMed ID: 35710247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From CURE to MATCH: ADP receptor antagonists as the treatment of choice for high-risk atherothrombotic patients.
    Hacke W
    Cerebrovasc Dis; 2002; 13 Suppl 1():22-6. PubMed ID: 11803184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.